About Pregenen
Pregenen, established in 2006 and currently in Acquired stage, focuses on limited information available. Limited information available. Adapting to market demands with innovation. It continues to evolve, meeting industry challenges with strategic approaches and commitment to quality.
- Headquarter Seattle, United States
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Bluebird Bio
(Jun 30, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Pregenen
Detailed funding history for Pregenen
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Pregenen
Pregenen has secured backing from 1 investor. Prominent investors backing the company include Bluebird Bio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Gene therapies for severe genetic and rare diseases are developed.
|
Locked | Locked | Locked |
Investor details for Pregenen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pregenen
Investment portfolio details for Pregenen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pregenen
Detailed financials for Pregenen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pregenen Comparisons
Peer comparison for Pregenen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pregenen
Detailed competitors of Pregenen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pregenen
Complete news archive for Pregenen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pregenen
Pregenen was founded in 2006.
Pregenen is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Pregenen, established in 2006 and currently in Acquired stage, focuses on limited information available. Limited information available. Adapting to market demands with innovation. It continues to evolve, meeting industry challenges with strategic approaches and commitment to quality.
Pregenen has 1 investor. Key investors include Bluebird Bio.